[Psychiatrists and the pharmaceutical industry]

Area of Science:

• Psychiatry and Pharmaceutical Industry Ethics
• Medical Professionalism

Context:

• Increasing frequency and intensity of psychiatrist-pharmaceutical industry relationships at individual and institutional levels.
• Spectrum of interactions ranging from cooperation to misconduct.
• Growing concern over ethical implications and patient trust.

Purpose:

• To address the ethical challenges posed by psychiatrist-pharmaceutical industry relationships.
• To propose recommendations for safeguarding physician and industry integrity.
• To prevent endangerment of the physician-patient relationship.

Summary:

• Reviews literature on psychiatrist-pharmaceutical industry interactions, noting a range from beneficial cooperation to misconduct.
• Highlights the need for clear norms, documentation, and disclosure to foster trust.
• Presents 27 recommendations for psychiatric associations to develop explicit guidelines.

Impact:

• Aims to establish clear ethical norms and documentation standards.
• Seeks to enhance mutual trust among physicians, the industry, and the public.
• Provides a framework for psychiatric associations to guide industry relationships.